Duration of antibody responses after severe acute respiratory syndrome

被引：294
|
作者：
Wu, Li-Ping
Wang, Nai-Chang
Chang, Yi-Hua
Tian, Xiang-Yi
Na, Dan-Yu
Zhang, Li-Yuan
Zheng, Lei
Lan, Tao
Wang, Lin-Fa
Liang, Guo-Dong [1 ]
机构：
[1] Shanxi Prov Ctr Dis Control & Prevent, Taiyuan, Peoples R China
[2] Shanxi Prov Peoples Hosp, Taiyuan, Peoples R China
[3] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia
[4] Australian Biosecurity Ctr Emerging Infect Dis, Geelong, Vic, Australia
[5] State Key Lab Infect Dis Control & Prevent, Beijing, Peoples R China
来源：
EMERGING INFECTIOUS DISEASES | 2007年 / 13卷 / 10期
关键词：
D O I：
10.3201/eid1310.070576
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Among 176 patients who had had severe acute respiratory syndrome (SARS), SARS-specific antibodies were maintained for an average of 2 years, and significant reduction of immunoglobulin G-positive percentage and titers occurred in the third year. Thus, SARS patients might be susceptible to reinfection >= 3 years after initial exposure.
引用
收藏
页码：1562 / 1564
页数：3
相关论文
共 50 条
  • [41] Respiratory protection and severe acute respiratory syndrome
    Nicas, M
    Harrison, R
    Charney, W
    Borwegan, B
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2004, 46 (03) : 195 - 197
  • [42] The Continuing Puzzle of Defining Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Infectivity
    Schiffer, Joshua T.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (12): : 1339 - 1342
  • [43] Middle East respiratory syndrome and severe acute respiratory syndrome
    Vijay, Rahul
    Perlman, Stanley
    CURRENT OPINION IN VIROLOGY, 2016, 16 : 70 - 76
  • [44] Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Kinetics and Protection Duration
    Dimeglio, Chloe
    Herin, Fabrice
    Da-Silva, Isabelle
    Porcheron, Marion
    Martin-Blondel, Guillaume
    Chapuy-Regaud, Sabine
    Izopet, Jacques
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E924 - E925
  • [45] Student nurses' ethical views on responses to the severe acute respiratory syndrome outbreak
    Kam, Joseph K. M.
    Chan, Eric
    Lee, Albert
    Wei, Vivian W., I
    Kwok, Kin On
    Lui, Dominic
    Yuen, Robert K. N.
    NURSING ETHICS, 2020, 27 (04) : 924 - 934
  • [46] Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome
    Sheng, WH
    Chiang, BL
    Chang, SC
    Ho, HN
    Wang, JT
    Chen, YC
    Hsiao, CH
    Hseuh, PR
    Chie, WC
    Yang, PC
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2005, 104 (10) : 715 - 723
  • [47] Dynamics of Different Classes and Subclasses of Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants after Coronavirus Disease 2019 and CoronaVac Vaccination in Thailand
    Poolchanuan, Prapassorn
    Matsee, Wasin
    Sengyee, Sineenart
    Siripoon, Tanaya
    Dulsuk, Adul
    Phunpang, Rungnapa
    Pisutsan, Phimphan
    Piyaphanee, Watcharapong
    Luvira, Viravarn
    Chantratita, Narisara
    MSPHERE, 2023, 8 (01)
  • [48] Severe acute respiratory distress syndrome after smoke bomb explosion
    Hillgaertner, F.
    Vanek, P.
    Kuhn, M.
    Frutiger, A.
    SWISS MEDICAL WEEKLY, 2010, 140 (13-14) : 17S - 18S
  • [49] Severe Acute Respiratory Syndrome Coronavirus-2 Antibody Responses in Hospitalized Patients with Coronavirus Disease 2019 in Daegu, Korea
    Kim, Yu Kyung
    Minn, Dohsik
    Yoo, Eun-Hyung
    Park, Mikyoung
    Lee, Jae Hee
    Ha, Jung-Sook
    Ham, Ji Yeon
    Chang, Soon Hee
    Lee, Hyun Chul
    Suh, Jang Soo
    Jeon, Chang-Ho
    Kim, Do-Hoon
    Park, Sunggyun
    Lee, Nan Young
    Song, Kyung Eun
    Kim, Soohyun
    Kim, Tae Yeob
    Kim, Sang-Gyung
    CLINICAL LABORATORY, 2021, 67 (11) : 2533 - 2539
  • [50] At the epicenter of severe acute respiratory syndrome
    Wan, S
    Yim, APC
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (06): : 1553 - 1557
12345